A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn's Disease [0.03%]
评估克罗恩病患者黏膜愈合的无创方法
William J Sandborn,Maria T Abreu,Marla C Dubinsky
William J Sandborn
Ongoing inflammation in the gastrointestinal tract and loss of the mucosal barrier are key components of Crohn's disease. Current treatment paradigms, including treat-to-target, are based on improvement of both clinical and endoscopic sympt...
Stephen B Hanauer
Stephen B Hanauer
A SPECIAL MEETING REVIEW EDITION: Highlights in Hepatitis C Virus From the 2017 AASLD Liver Meeting: A Review of Selected Presentations From the 2017 AASLD Liver Meeting • October 20-24, 2017 • Washington, DC Special Reporting on:• Efficacy, Safety, and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus In [0.03%]
美国肝病研究协会年会亮点：2017 AASLD 肝脏会议丙型肝炎病毒领域综述报告摘要选编 • 2017 年 10 月 20 日至 24 日，华盛顿特区 特别报导：• Glecaprevir/Pibrentasvir 治疗成人基因1-6型慢性丙型肝炎患者的疗效、安全性和药代动力学
Vivek Kaul
Vivek Kaul
Guy E Boeckxstaens
Guy E Boeckxstaens
Risk of Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis [0.03%]
非酒精性脂肪肝病患者的肝细胞癌风险
Michael Charlton
Michael Charlton
Safety and Positioning of Vedolizumab in Patients With Inflammatory Bowel Disease [0.03%]
维多珠单抗在炎症性肠病患者中的安全性及定位研究
Brian Feagan
Brian Feagan
Andrew Aronsohn
Andrew Aronsohn
Seth A Gross,Joseph Kingsbery,Janice Jang et al.
Seth A Gross et al.
Barrett esophagus (BE) is the precursor lesion to adenocarcinoma of the esophagus. The current surveillance strategy of 4-quadrant Seattle protocol biopsies has been associated with sampling error and missing higher-risk lesions, and there ...
Zaheer Nabi,D Nageshwar Reddy,Mohan Ramchandani
Zaheer Nabi
The capabilities of interventional gastrointestinal endoscopy have significantly increased over the past several decades. Improvements in devices and techniques have eased the transfer of novel concepts from bench to bedside. The concept of...